Literature DB >> 1742646

Fibroblasts and asthma.

W R Roche1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1742646     DOI： 10.1111/j.1365-2222.1991.tb00845.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  7 in total

Review 1.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

2.  In vivo restitution of airway epithelium.

Authors:  J S Erjefält; I Erjefält; F Sundler; C G Persson
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

3.  Basement membrane components of bronchial epithelium in humans suffering from chronic nonspecific lung diseases.

Authors:  M Pilmane; M Magone; A Luts; F Sundler; A Dalmane
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

4.  Synergistic action of endothelin (ET)-1 on the activation of bronchial fibroblast isolated from normal and asthmatic subjects.

Authors:  J Dubé; J Chakir; C Dubé; Y Grimard; M Laviolette; L P Boulet
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 5.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

6.  Deficient Follistatin-like 3 Secretion by Asthmatic Airway Epithelium Impairs Fibroblast Regulation and Fibroblast-to-Myofibroblast Transition.

Authors:  Richard G James; Stephen R Reeves; Kaitlyn A Barrow; Maria P White; Veronika A Glukhova; Candace Haghighi; Dana Seyoum; Jason S Debley
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 7.748

7.  Effects of ozone stimulation of bronchial epithelial cells on proliferation and collagen synthesis of co-cultured lung fibroblasts.

Authors:  Yue Wang; Meiling Tan; Haiping Ouyang; Linhong Deng
Journal:  Exp Ther Med       Date:  2018-05-02       Impact factor: 2.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.